PRINCIPAL FINANCIAL GROUP INC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1126328
DES MOINES, IA
Position in ARWR
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$41,949,773
+$11,219,124 QoQ
Shares Held
514,658
+5.0% QoQ
Ownership
0.364%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#42
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. ARWR ranks #12 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,949,773 | 514,658 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $30,730,649 | 490,122 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $47,504,633 | 715,539 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $26,906,752 | 780,132 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $9,844,932 | 623,097 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $8,014,414 | 629,075 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $5,431,019 | 288,884 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $5,636,553 | 290,994 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $11,039,667 | 424,766 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $13,845,831 | 484,120 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $12,602,518 | 411,847 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $11,062,969 | 411,722 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $14,943,750 | 419,062 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $11,278,031 | 444,017 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $17,560,735 | 432,957 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $14,152,604 | 428,218 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $15,259,484 | 433,385 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $17,433,658 | 379,075 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $28,370,299 | 427,908 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $27,644,940 | 442,815 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $42,831,770 | 517,167 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $34,336,643 | 517,820 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $26,451,745 | 344,738 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $14,286,877 | 331,790 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $14,767,437 | 341,918 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $11,015,169 | 382,870 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||